We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 4,546

Network interference - a legal guide to the commercial risks and rewards of the social media phenomenon
  • Reed Smith LLP
  • European Union, Global, United Kingdom, USA
  • April 22 2014

Social media is a revolution in the way in which corporations communicate with consumers. This White Paper will help you to maximise the huge


Mobile App Compliance for Dummies: New Tool Helps Developers Understand Their Legal Compliance Requirements
  • Reed Smith LLP
  • USA
  • April 21 2016

In a joint effort by the Federal Trade Commission (FTC), Office for Civil Rights (OCR), HHS Office of National Coordinator for Health Information


Innovator Drug510k Medical Device Impossibility Preemption and the Meaning of “A Fortiori”
  • Reed Smith LLP
  • USA
  • April 22 2016

According to Black's Law Dictionary, "a fortiori" is legal Latin meaning: By even greater force of logic; even more so it follows . We've been


Veterans Affairs to Permit Acquisition of Non-TAA-Compliant Drugs
  • Reed Smith LLP
  • USA
  • April 22 2016

In a significant policy reversal, the Department of Veterans Affairs (VA) has announced that it will require all covered drugs under the Veterans


New VA Policy to Have Immediate Impact on Many Pharmaceutical Manufacturers, Suppliers
  • Reed Smith LLP
  • USA
  • April 25 2016

In a significant policy reversal that will affect many pharmaceutical manufacturers and suppliers - and that will require immediate action by many


TPPs Fail to Put Their Money Where Their (Litigation) Mouth Is and Lose
  • Reed Smith LLP
  • USA
  • April 20 2016

In third party payor litigation over prescription medical products, we have often marveled at the causation arguments that plaintiffs have offered


CMS announces "winners" of Medicare DMEPOS competitive bidding round 2National Mail order competition
  • Reed Smith LLP
  • USA
  • April 16 2013

On April 9, 2013, CMS announced the names of 799 suppliers that have been awarded 3-year contracts under Round 2 of the Medicare durable medical


Gutsy Gatekeeping: Plaintiffs’ Experts Excluded in Lipitor MDL
  • Reed Smith LLP
  • USA
  • April 19 2016

This week, as Drug and Device Law Jews, we are preparing for Passover, which, like most Jewish holidays, begins with a multi-generational dinner at


Who heeds the heeding presumption?
  • Reed Smith LLP
  • USA
  • November 7 2014

We've made no secret of our distaste for the so called "heeding presumption" - that juries may presume that any alternative "adequate" warning would


Litigation over “meal replacement” cannot replace FDA’s primary jurisdiction
  • Reed Smith LLP
  • USA
  • December 5 2013

The recent Thanksgiving weekend and the hearty meals that exemplify that great American holiday give us a segue to a post on food. Specifically we